Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study

Detalhes bibliográficos
Autor(a) principal: Horvat, Natally
Data de Publicação: 2023
Outros Autores: Araujo-Filho, Jose de Arimateia B., Assuncao-Jr, Antonildes N., Machado, Felipe Augusto de M., Sims, John A., Rocha, Camila Carlos Tavares, Oliveira, Brunna Clemente, Horvat, Joao Vicente, Maccali, Claudia, Puga, Anna Luísa Boschiroli Lamanna, Chagas, Aline Lopes, Menezes, Marcos Roberto, Cerri, Giovanni Guido
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Clinics
Texto Completo: https://www.revistas.usp.br/clinics/article/view/212986
Resumo: OBJECTIVES: To investigate whether quantitative textural features, extracted from pretreatment MRI, can predict sustained complete response to radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC). METHODS: In this IRB-approved study, patients were selected from a maintained six-year database of consecutive patients who underwent both pretreatment MRI imaging with a probable or definitive imaging diagnosis of HCC (LI-RADS 4 or 5) and loco-regional treatment with RFA. An experienced radiologist manually segmented the hepatic nodules in MRI arterial and equilibrium phases to obtain the volume of interest (VOI) for extraction of 107 quantitative textural features, including shape and first- and second-order features. Statistical analysis was performed to evaluate associations between textural features and complete response. RESULTS: The study consisted of 34 patients with 51 treated hepatic nodules. Sustained complete response was achieved by 6 patients (4 with single nodule and 2 with multiple nodules). Of the 107 features from the arterial and equilibrium phases, 20 (18%) and 25 (23%) achieved AUC >0.7, respectively. The three best performing features were found in the equilibrium phase: Dependence Non-Uniformity Normalized and Dependence Variance (both GLDM class, with AUC of 0.78 and 0.76, respectively) and Maximum Probability (GLCM class, AUC of 0.76). CONCLUSIONS: This pilot study demonstrates that a radiomic analysis of pre-treatment MRI might be useful in identifying patients with HCC who are most likely to have a sustained complete response to RFA. Second-order features (GLDM and GLCM) extracted from equilibrium phase obtained highest discriminatory performance.
id USP-19_10f8b892019a99f1116a52b6fe8e14c3
oai_identifier_str oai:revistas.usp.br:article/212986
network_acronym_str USP-19
network_name_str Clinics
repository_id_str
spelling Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot StudyCarcinoma HepatocellularMagnetic Resonance ImagingRadiomicsRadiofrequency AblationOBJECTIVES: To investigate whether quantitative textural features, extracted from pretreatment MRI, can predict sustained complete response to radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC). METHODS: In this IRB-approved study, patients were selected from a maintained six-year database of consecutive patients who underwent both pretreatment MRI imaging with a probable or definitive imaging diagnosis of HCC (LI-RADS 4 or 5) and loco-regional treatment with RFA. An experienced radiologist manually segmented the hepatic nodules in MRI arterial and equilibrium phases to obtain the volume of interest (VOI) for extraction of 107 quantitative textural features, including shape and first- and second-order features. Statistical analysis was performed to evaluate associations between textural features and complete response. RESULTS: The study consisted of 34 patients with 51 treated hepatic nodules. Sustained complete response was achieved by 6 patients (4 with single nodule and 2 with multiple nodules). Of the 107 features from the arterial and equilibrium phases, 20 (18%) and 25 (23%) achieved AUC >0.7, respectively. The three best performing features were found in the equilibrium phase: Dependence Non-Uniformity Normalized and Dependence Variance (both GLDM class, with AUC of 0.78 and 0.76, respectively) and Maximum Probability (GLCM class, AUC of 0.76). CONCLUSIONS: This pilot study demonstrates that a radiomic analysis of pre-treatment MRI might be useful in identifying patients with HCC who are most likely to have a sustained complete response to RFA. Second-order features (GLDM and GLCM) extracted from equilibrium phase obtained highest discriminatory performance.Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo2023-06-10info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/clinics/article/view/21298610.6061/clinics/2021/e2888Clinics; v. 76 (2021); e2888Clinics; Vol. 76 (2021); e2888Clinics; Vol. 76 (2021); e28881980-53221807-5932reponame:Clinicsinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/clinics/article/view/212986/195008Copyright (c) 2023 Clinicsinfo:eu-repo/semantics/openAccessHorvat, NatallyAraujo-Filho, Jose de Arimateia B.Assuncao-Jr, Antonildes N.Machado, Felipe Augusto de M.Sims, John A.Rocha, Camila Carlos TavaresOliveira, Brunna ClementeHorvat, Joao VicenteMaccali, ClaudiaPuga, Anna Luísa Boschiroli LamannaChagas, Aline LopesMenezes, Marcos RobertoCerri, Giovanni Guido2023-06-10T20:36:44Zoai:revistas.usp.br:article/212986Revistahttps://www.revistas.usp.br/clinicsPUBhttps://www.revistas.usp.br/clinics/oai||clinics@hc.fm.usp.br1980-53221807-5932opendoar:2023-06-10T20:36:44Clinics - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study
title Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study
spellingShingle Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study
Horvat, Natally
Carcinoma Hepatocellular
Magnetic Resonance Imaging
Radiomics
Radiofrequency Ablation
title_short Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study
title_full Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study
title_fullStr Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study
title_full_unstemmed Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study
title_sort Radiomic analysis of MRI to Predict Sustained Complete Response after Radiofrequency Ablation in Patients with Hepatocellular Carcinoma - A Pilot Study
author Horvat, Natally
author_facet Horvat, Natally
Araujo-Filho, Jose de Arimateia B.
Assuncao-Jr, Antonildes N.
Machado, Felipe Augusto de M.
Sims, John A.
Rocha, Camila Carlos Tavares
Oliveira, Brunna Clemente
Horvat, Joao Vicente
Maccali, Claudia
Puga, Anna Luísa Boschiroli Lamanna
Chagas, Aline Lopes
Menezes, Marcos Roberto
Cerri, Giovanni Guido
author_role author
author2 Araujo-Filho, Jose de Arimateia B.
Assuncao-Jr, Antonildes N.
Machado, Felipe Augusto de M.
Sims, John A.
Rocha, Camila Carlos Tavares
Oliveira, Brunna Clemente
Horvat, Joao Vicente
Maccali, Claudia
Puga, Anna Luísa Boschiroli Lamanna
Chagas, Aline Lopes
Menezes, Marcos Roberto
Cerri, Giovanni Guido
author2_role author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Horvat, Natally
Araujo-Filho, Jose de Arimateia B.
Assuncao-Jr, Antonildes N.
Machado, Felipe Augusto de M.
Sims, John A.
Rocha, Camila Carlos Tavares
Oliveira, Brunna Clemente
Horvat, Joao Vicente
Maccali, Claudia
Puga, Anna Luísa Boschiroli Lamanna
Chagas, Aline Lopes
Menezes, Marcos Roberto
Cerri, Giovanni Guido
dc.subject.por.fl_str_mv Carcinoma Hepatocellular
Magnetic Resonance Imaging
Radiomics
Radiofrequency Ablation
topic Carcinoma Hepatocellular
Magnetic Resonance Imaging
Radiomics
Radiofrequency Ablation
description OBJECTIVES: To investigate whether quantitative textural features, extracted from pretreatment MRI, can predict sustained complete response to radiofrequency ablation (RFA) in patients with hepatocellular carcinoma (HCC). METHODS: In this IRB-approved study, patients were selected from a maintained six-year database of consecutive patients who underwent both pretreatment MRI imaging with a probable or definitive imaging diagnosis of HCC (LI-RADS 4 or 5) and loco-regional treatment with RFA. An experienced radiologist manually segmented the hepatic nodules in MRI arterial and equilibrium phases to obtain the volume of interest (VOI) for extraction of 107 quantitative textural features, including shape and first- and second-order features. Statistical analysis was performed to evaluate associations between textural features and complete response. RESULTS: The study consisted of 34 patients with 51 treated hepatic nodules. Sustained complete response was achieved by 6 patients (4 with single nodule and 2 with multiple nodules). Of the 107 features from the arterial and equilibrium phases, 20 (18%) and 25 (23%) achieved AUC >0.7, respectively. The three best performing features were found in the equilibrium phase: Dependence Non-Uniformity Normalized and Dependence Variance (both GLDM class, with AUC of 0.78 and 0.76, respectively) and Maximum Probability (GLCM class, AUC of 0.76). CONCLUSIONS: This pilot study demonstrates that a radiomic analysis of pre-treatment MRI might be useful in identifying patients with HCC who are most likely to have a sustained complete response to RFA. Second-order features (GLDM and GLCM) extracted from equilibrium phase obtained highest discriminatory performance.
publishDate 2023
dc.date.none.fl_str_mv 2023-06-10
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/clinics/article/view/212986
10.6061/clinics/2021/e2888
url https://www.revistas.usp.br/clinics/article/view/212986
identifier_str_mv 10.6061/clinics/2021/e2888
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/clinics/article/view/212986/195008
dc.rights.driver.fl_str_mv Copyright (c) 2023 Clinics
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2023 Clinics
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
publisher.none.fl_str_mv Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo
dc.source.none.fl_str_mv Clinics; v. 76 (2021); e2888
Clinics; Vol. 76 (2021); e2888
Clinics; Vol. 76 (2021); e2888
1980-5322
1807-5932
reponame:Clinics
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Clinics
collection Clinics
repository.name.fl_str_mv Clinics - Universidade de São Paulo (USP)
repository.mail.fl_str_mv ||clinics@hc.fm.usp.br
_version_ 1787713182945509376